openPR Logo
Press release

Organoids Market is expected to reach US$ 3,420.40 million by 2027 With STEMCELL Technologies, Cellesce Ltd., Hubrecht Organoid Technology, Definigen, 3Dnamics, Organoid Therapeutics, PeproTech, Thermo Fisher Scientific, Corning Incorporated (Life Science

05-07-2021 05:30 PM CET | Health & Medicine

Press release from: The Insight Partners

/ PR Agency: The Insight Partners
Organoids Market

Organoids Market

According to our new research study on “Organoids Market to 2027 – Global Analysis and Forecast – by Type, Application, and Source,” the organoids market was valued at US$ 689.47 million in 2019 and is projected to reach US$ 3,420.40 million by 2027; it is expected to grow at a CAGR of 22.1% during 2020–2027. The growth of the market is attributed to increasing demand for tumor modelling and biobanking, escalating adoption of personalized drugs, and growing focus on developing alternatives for animal testing models. However, issues related to the incorporation of organoids into existing workflows and dearth of skilled professionals hinder the growth of the market. `

Request Sample Copy of Organoids Market research report at – https://www.theinsightpartners.com/sample/TIPRE00017616/?openpr-10225

Company Profiles

STEMCELL Technologies, Inc.
Cellesce Ltd.
Hubrecht Organoid Technology
Definigen
3Dnamics, Inc.
Organoid Therapeutics
PeproTech, Inc.
Thermo Fisher Scientific
Corning Incorporated (Life Sciences)
Merck KGgA

In 2019, North America dominated the global organoids market. The market growth in the region is credited to the rise in the implementation of organoid-based research models in the biotechnology sector in US and Canada. These novel technologies have helped the researchers to overcome limitations faced by 2D cell culture platforms as 3D spheroids offer a microenvironment that can mimic the properties of human tissue structures. The market growth in Canada and Mexico is attributed to the presence of international market players, increasing adoption of advanced technologies, and existence of supportive government regulations. Based on type, the organoids market is segmented into stomach, intestine, liver, pancreas, lung, brain, kidney, and lung. The intestine segment accounted for more than 23.31% of the market in 2019. On the basis of application, the organoids market is segmented into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease segment is expected to held the largest share of the market in 2019 owing to its consideration as primary investigative research tool of the human developmental biology. Further, the pluripotent stem cells segment accounted for a larger share in the organoids market, by source, in 2019.

Increasing Use of Personalized Drugs Fuels Organoids Market Growth

Personalized medicine is a flourishing area of therapeutics that relies on specific drug delivery and dosing. As per a study published by PMC, personalized medicines accounted for only 5% of the new FDA-approved molecular entities in 2005, whereas they accounted for more than 25% in 2016. Additionally, 42% of all compounds and 73% of oncology compounds in the pipeline have the potential to be prescribed as personalized medicines. Biopharmaceutical companies have nearly doubled their R&D investments in personalized drugs in the past five years, and they are further likely to increase by 33% in the next five years. Biopharmaceutical researchers also predict a 69% increase in the development of personalized medicines over the coming five years.

The implementation of organoids to create personalized drug therapies is providing exciting opportunities for improving patient care. Recent research has highlighted that more than 50% of consumers express an interest in purchasing customized products or services. Since the release of the Precision Medicine Initiative in the US in 2015, pharmaceutical researchers have been pursuing the development of more tailored treatments for making medicines safer and more effective.

Personalized cancer therapy involves using personalized tumor models with similar characteristics to the original tumors, which may result in accurate predictions of drug responses in patients. One of the key advantages of tumor organoid models involve the conservation of molecular and cellular composition of the original tumor, which highlights the tremendous potential of tumor organoids in personalized cancer therapy, particularly in preclinical drug screening and predicting patient responses to selected treatment regimens.

Organoids Market: Segmental Overview

In terms of type, the kidney organoids segment is anticipated to register the highest CAGR in the organoids market during the forecast period. Kidney organoids, derived from human pluripotent stem cells, have the potential to assist the drug development process. An international team of researchers—led by Nanyang Technological University Singapore (NTU Singapore)—has grown “miniature kidneys” in laboratory, which could be used to better understand the mechanism of development of renal diseases in individual patients. The mini kidneys, i.e., kidney organoids, were grown in vitro from skin cells derived from a single patient who had polycystic kidney disease, one of the most common inherited causes of kidney failure in adults. In terms of application, the developmental biology disease segment accounted for more than 29% share in global organoids market in 2019. In terms of source, the market for the pluripotent stem cells segment is anticipated to grow at a higher CAGR during the forecast period.

Organoids Market: Competition Landscape and Key Developments

STEMCELL Technologies, Inc, Cellesce Ltd., Hubrecht Organoid Technology, Definigen, 3Dnamics, Inc., Organoid Therapeutics, PeproTech, Inc., Thermo Fisher Scientific, Corning Incorporated (Life Sciences) and Merck KGgA. are among the key companies operating in the global organoids market. Leading players are focusing on the expansion and diversification of their market presence, and acquisition of new customer base, thereby tapping prevailing business opportunities.

In October 2019, Corning Incorporated launched two new products—Elplasia and Matrigel—to its organoid culture portfolio to provide new solutions to support spheroid and organoid culture models. Elplasia, a 3D cell culture microplate, features a microcavity technology that enables high-volume spheroid formation, culture, and analysis. The Matrigel matrix for organoid culture is optimized to support organoid growth and differentiation.

In Sep-2018, STEMCELL Technologies Signed a partnership agreement with Brigham and Women’s Hospital to commercialize a human pluripotent stem cell-derived kidney organoid culture system.

Market Segmentation

By Type

Stomach
Intestine
Liver
Pancreas
Lung
Brain
Kidney
Others

By Application

Developmental Biology
Disease Pathology of Infectious Disease
Regenerative Medicine
Drug Toxicity and Efficacy Testing
Drug Discovery and Personalized Medicine
Others

By Source

Pluripotent Stem Cells
Organ-Specific Adult Stem Cells

By Geography

North America
US
Canada
Mexico
Europe
France
Germany
UK
Italy
Spain
Rest of Europe
Asia Pacific (APAC)
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Middle East & Africa (MEA)
Saudi Arabia
South Africa
UAE
Rest of Middle East & Africa
South America (SCAM)
Brazil
Argentina
Rest of South & Central America

Order a copy of this research Organoids Market research report at – https://www.theinsightpartners.com/buy/TIPRE00017616/?openpr-10225

Contact US:
If you have any queries about this report or would like further information, please contact us:
North America: +1 646 491 9876
Asia-Pacific: +91 20 6727 8686
Email: sales@theinsightpartners.com

ABOUT US:
The Insight Partners is a one stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Our research model is very simple. We believe in client servicing and delivering best quality to our customers. Through our research content, we are making sure that our customers get value of their money along with better quality data and analysis.
Our research content is majorly focused towards market trends in terms of market sizing, competitive landscaping, company analysis, regional or country analysis etc. We provide detailed break-up of segmentation in terms of geography, technology, product and services etc.; which helps our clients to get a deeper analysis on various research topics.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Organoids Market is expected to reach US$ 3,420.40 million by 2027 With STEMCELL Technologies, Cellesce Ltd., Hubrecht Organoid Technology, Definigen, 3Dnamics, Organoid Therapeutics, PeproTech, Thermo Fisher Scientific, Corning Incorporated (Life Science here

News-ID: 2281753 • Views:

More Releases from The Insight Partners

Dental Imaging Equipment Market Analysis, Opportunities, Growth Forecast To 2031
Dental Imaging Equipment Market Analysis, Opportunities, Growth Forecast To 2031
The Insight Partners recently announced the release of the market research titled Dental Imaging Equipment Market Outlook to 2031 | Share, Size, and Growth. The report is a stop solution for companies operating in the Dental Imaging Equipment market. The report involves details on key segments, market players, precise market revenue statistics, and a roadmap that assists companies in advancing their offerings and preparing for the upcoming decade. Listing out
Orthopedic 3D Scanners Market Is Gaining Huge Growth In Upcoming Years
Orthopedic 3D Scanners Market Is Gaining Huge Growth In Upcoming Years
3D orthopaedic scanning devices are sophisticated technology-driven systems used to scan human body components for the detection and treatment of the defect. By means of its scanning capabilities, 3D orthopaedic scanning systems help to design uniquely customised products and to find further use in surgical procedures. Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00017457/?utm_source=OpenPR&utm_medium=10129 Orthopedic 3D Scanners Market: Competitive Landscape and Key Developments: • Delcam Plc • Allied OSI Labs • SCANNY3D S.r.l. • AGE Solutions S.r.l. • Orthopaedic Innovation Centre • Diasu
Prostate Cancer Diagnostics: A Guide to Understanding the Process
Prostate Cancer Diagnostics: A Guide to Understanding the Process
Prostate cancer diagnostics refers to the various tests and procedures used to diagnose prostate cancer in men. Early detection of prostate cancer is important for successful treatment and recovery. Several different diagnostic tests are available, including digital rectal exams, prostate-specific antigen (PSA) tests, and biopsies. With the increasing prevalence of prostate cancer. Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00003656/?utm_source=OpenPR&utm_medium=10129 Prostate Cancer Diagnostics Market: Competitive Landscape and Key Developments: • MDxHealth • Telo Genomics Corp
Aerospace Plastics Market Research Insights with Upcoming Trends Segmentation, Opportunities and Forecast to 2031
Aerospace Plastics Market Research Insights with Upcoming Trends Segmentation, O …
The Aerospace Plastics Market report by "The Insight Partners" entails detailed information regarding the dynamics affecting market valuation over the analysis period. It also covers the competitive landscape, market scope, and market segmentation. Get Sample Copy of Report at: https://www.theinsightpartners.com/sample/TIPRE00005464/?utm_source=OpenPR&utm_medium=10188 Companies Profiled in this report includes: • SABIC • Victrex • Drake Plastics Ltd • Solvay • BASF SE • Evonik Industries AG • Vantage Plane Plastics • Paco Plastics & Engineering Inc. • 3P • Performance Plastics Products • Big Bear Plastics The report scrutinizes different business approaches and frameworks that

All 5 Releases


More Releases for Organoid

Organoids Market Driven By Definigen, Organoid Therapeutics, Hubrecht Organoid T …
The scope of the organoids market includes type, application, source, and region. The organoids market is analyzed based on regions, such as North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the organoids market emphasizing on various parameters, such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the globe.
Organoids Market Witness Heightened Revenue of US$ 3,420.40 million by 2027 with …
The Organoids Market was valued at US$ 689.47 million in 2019 and it is projected to reach US$ 3,420.40 million by 2027; it is expected to grow at a CAGR of 22.1% from 2020 to 2027. Organoids are tiny, self-organized three-dimensional tissue cultures that are derived from stem cells. Such cultures can be crafted to replicate much of the complexity of an organ, or to express selected aspects of it like
Organoid Research Market Development Trends & Competitive Analysis by Leading In …
Global Organoids Market: An Overview The global organoids Market is a fragmented landscape with several new players driving intense competition and rising investment in innovation. Recent advancements in Big Data, and technologies like 3D printing have opened up new skies of growth for innovation. Organoids is a simplified and compact version of organs which depicts micro-anatomy realistically. These are usually made up of stem cells, tissues, or pluripotent stem cells. These can
Cancer Tumor Organoid Modifying the Overall Cancer Market Scenario
Within no time, the organoid cultures for cancer treatment have emerged as one of the most powerful modeling system in the field of cancer biology. From the very beginning of the market, it has been experiencing high adoption rate among the researchers and patients, minimum side effects and maximum appreciation for being unique among all the other 2-D model systems available in the market. The arrival of cancer organoids by
Global Organoid Kit Market to Witness a Pronounce Growth During 2024
LP INFORMATION offers a latest published report on Organoid Kit Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Organoid Kit market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular,
Organoid Kit Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Organoid Kit Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Organoid Kit players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Organoid Kit with respect to individual growth